Eton Pharmaceuticals, Inc.
ETON • NASDAQ
Eton Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean E. Brynjelsen, with a market cap of $634.1M.
Market Cap$634.1M
Employees30.0
CEOSean E. Brynjelsen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Eton Pharmaceuticals, Inc. FAQ
Common questions about Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $22.3M.
Eton Pharmaceuticals, Inc. has approximately 30 employees.